50
Participants
Start Date
March 31, 2005
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD)
"rituximab 375 mg/m2 IV Weekly x 4 1 cycle only~dexamethasone 40 mg PO/IV Days 2-5 q 21 days 2 cycles~oxaliplatin 130 mg/m2 IV Day 2 q 21 days 2 cycles~cytosine arabinoside 2000 mg/m2 x 2 doses IV Days 2-3 q 21 days 2 cycles~pegfilgrastim 6 mg SQ Day 4 q21 days 2 cycles"
Mayo Clinic, Rochester
Collaborators (1)
Mayo Clinic
OTHER
Academic and Community Cancer Research United
OTHER